Jin C et al., 2021-04-16: A paper on methylene blue photochemical inactivation of SARS-CoV-2 in plasma that PubMed indexes as a retracted publication. It is recorded because a retracted paper is part of the record and must not be relied on.
Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19.
Jin C et al., 2021-04-16: A paper on methylene blue photochemical inactivation of SARS-CoV-2 in plasma that PubMed indexes as a retracted publication. It is recorded because a retracted paper is part of the record and must not be relied on. Study type: laboratory study – RETRACTED PUBLICATION (PubMed publication type 'Retracted Publication'). N=not applicable. Country: China. Note: the excerpt is the article title as indexed (record field). The retraction means this paper cannot be cited as support for antiviral claims; it is recorded at full strength so the record shows that one of the most-cited methylene blue/COVID papers was withdrawn. Study type: lab.
